29 October 2019 - “Three hundred forty-five billion dollars in savings versus the cost of eight to 15 fewer drugs over 10 years, I frankly think it’s worth it.”

In the above quote, Representative Soto is defending H.R. 3, the drug price control bill Speaker Nancy Pelosi is advocating. While the Congressman believes that the costs of price controls are “worth it”, patients living with diseases that lack an effective treatment may disagree.

While there has been impressive progress recently, there are still too many diseases that devastate the lives of patients and their caregivers, but lack an effective treatment. Patients that are living with these diseases – such as pancreatic cancer, Alzheimer’s disease, and muscular dystrophy – all have hope that an effective treatment is just around the corner.

Read Forbes article